title: Survival of ovarian cancer in Iran: 2000-2004.
abstract: OBJECTIVE
  The aim of this study was to estimate the 5-year survival of ovarian cancer in Iran between 2000 and 2004, according to age and histology.
  
  
  METHODS
  Cancer registry of Iran, 2000-2004, was used covering nearly 80% of all ovarian cancers and 100% of all pathologically diagnosed ovarian cancers.
  
  
  RESULTS
  Of 1,246 new ovarian cancer cases, 451 were available for further follow-up, which revealed 169 deaths and 282 live cases. The 5-year survival was 61%; 85% for germ cell tumors and 59% for epithelial tumors. Survival of serous, mucinous, endometrioid and clear cell histologic subtypes of epithelial tumors was 41%, 62%, 76% and 78%, respectively. Young patients with epithelial tumors (below 45) displayed significantly better 5-year survival rates (63% versus 53%).
  
  
  CONCLUSIONS
  we found that ovarian cancer had a better survival rate in Iran in comparison to other regions. We also reviewed all probable confounding factors or real causes. In this study, age and histology affected survival.
authors.affiliation: Cancer Research Center, Department of Gynecology-Oncology, Shahid Beheshti University, Tehran, Iran.
authors.forename: Maliheh
authors.initials: M
authors.lastname: Arab
authors.forename: Maryam
authors.initials: M
authors.lastname: Khayamzadeh
authors.forename: Mitra
authors.initials: M
authors.lastname: Mohit
authors.forename: Maryam
authors.initials: M
authors.lastname: Hosseini
authors.forename: Robab
authors.initials: R
authors.lastname: Anbiaee
authors.forename: Morteza
authors.initials: M
authors.lastname: Tabatabaeefar
authors.forename: Mojgan
authors.initials: M
authors.lastname: Ebrahimi
authors.forename: Afseneh
authors.initials: A
authors.lastname: Tehranian
authors.forename: Mohammad Esmaeil
authors.initials: ME
authors.lastname: Akbari
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000401:mortality* / Q000556:secondary; D002288:Adenocarcinoma, Mucinous / Q000401:mortality* / Q000556:secondary; D000367:Age Factors; D018284:Cystadenocarcinoma, Serous / Q000401:mortality* / Q000556:secondary; D016889:Endometrial Neoplasms / Q000401:mortality* / Q000556:secondary; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality* / Q000473:pathology; D011379:Prognosis; D012042:Registries; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors